Examine the surface, lid margin and conjunctiva, recognise masquerade lesions and choose biopsy and tumour treatment by the actual diagnosis and risk.
Terminology and draft status
Terminology review is not complete. No new WHO UMD entry verification is claimed; pending entries and limits are recorded in terminology.md.
01Inspect the lid and protect its function
Inspect at the slit lamp and from a distance, palpate texture and fixation, and compare symmetry, lid position, lashes, gland openings and conjunctiva. Record duration, change, pain, bleeding, recurrence, prior treatment and immune suppression. Surface symptoms can reflect mechanical laxity, inflammation or a tumour; do not diagnose all persistent irritation as dry eye. 1
02Recognise floppy eyelid and assess sleep-apnoea symptoms
Floppy eyelid syndrome(FES) features an easily everted rubbery upper tarsus, papillary tarsal conjunctivitis and surface irritation, often with mucus, redness, ptosis or keratopathy. Reduced elastin is a proposed structural contributor, not a proven single cause in every patient. Examine actual laxity and exposure rather than treating symptoms alone. 1
FES is associated with obstructive sleep apnoea(OSA), not a diagnostic test for it. Ask about snoring, observed apnoeas and daytime sleepiness and arrange medical/sleep assessment when indicated. Untreated OSA can carry cardiopulmonary consequences, including pulmonary hypertension/right-heart strain in relevant patients; not every FES patient has these complications. 1 9
In CPAP users, assess mask leakage and fit; air regurgitation through the lacrimal drainage system is a distinct problem, particularly after DCR or a Jones tube. Do not assume every ocular air leak travels backwards through the canaliculi or advise stopping prescribed CPAP without the treating team. Lubrication and a suitable night shield may protect the surface; selected lid tightening/LTS or wedge excision depends on laxity, anatomy and canalicular protection, not a universal central/lateral site rule. 1 10 11
03Distinguish chalazion from acute infection
Chalazion is a chronic lipogranulomatous response to obstructed meibomian secretion; hordeolum is an acute infection, external at Zeis/Moll glands or internal at a meibomian gland. A recurrent or atypical apparent chalazion needs examination for a masquerading sebaceous carcinoma rather than repeated empirical treatment. 1 2 3
Warm compresses, gentle massage and lid hygiene are reasonable initial measures; multiple lesions also prompt assessment for meibomian dysfunction or rosacea. Routine antibiotics do not treat the sterile granuloma; suspected bacterial cellulitis has its own indication for systemic treatment, not simply the label “danger triangle”. 1 2 4 12
In a multicentre randomized trial, 149 patients received compresses alone or with tobramycin or tobramycin/dexamethasone for 4–6 weeks. Complete resolution occurred in 18% of lesions overall, with no significant between-group difference; this does not establish an added benefit of routine combination drops. Lesions and patients are different denominators; full methods and follow-up attrition were not appraised here. 4
Persistent or functionally troublesome chalazia may be treated by incision and curettage or selected intralesional triamcinolone. A single-centre randomized study of 136 patients reported resolution at 3 weeks of 84%, 87% and 46% for injection, surgery and compresses respectively. Short follow-up, telephone assessment and the abstract’s inconsistent P-value wording prevent a general equivalence or long-term safety claim. 2 5
Steroid injection can cause skin depigmentation, fat atrophy, pressure rise, penetration and visual loss. A conjunctival route may reduce skin exposure but does not eliminate risk; the export’s specific “fat embolism” explanation remains unverified rather than an established mechanism. 1 2 12
The source contrasts a vertical conjunctival incision with a cruciate incision and warns about glands and the nearby punctum. These are operative teaching points, not a self-contained technique: confirm anatomy and diagnosis. A chalazion is not a true epithelial cyst; “complete capsule removal” must not be read as a universal instruction for aggressive tissue stripping. 1 12
Tea-tree products are not an obligatory or universally ideal lid-hygiene choice and can irritate the ocular surface. Oral doxycycline may be considered for selected associated rosacea/meibomian disease, not automatically for every recurrence. The original under 8 years warning does not establish one universal modern contraindication for every indication, and it does not mandate azithromycin/clarithromycin for every child; verify the actual paediatric indication, product information and local guidance. 1
04Describe benign patterns without assuming certainty
Seborrhoeic keratosis often looks stuck on; verruca may relate to HPV, and molluscum contagiosum can cause chronic follicular conjunctivitis. Sebaceous hyperplasia and hidrocystoma are adnexal differentials; a translucent cyst may transilluminate but this is not universal or sufficient to exclude another lesion. Treat an uncertain or changing lesion according to diagnostic risk rather than appearance alone. 1
Medial yellow xanthelasma plaques justify considering lipid/systemic risk assessment, but not every patient has hypercholesterolaemia. Discuss recurrence, scarring and lid-position risks of cosmetic treatment. Junctional, compound and dermal naevi describe cellular location, not a guarantee from pigmentation or hair. Oculodermal melanocytosis/naevus Ota needs ocular assessment; the original 1:400 uveal-melanoma figure is population-specific and unverified here, not an individual risk prediction. 1
Actinic keratosis is a rough UV-related keratinocytic lesion with variable progression risk. Biopsy/excision or field treatment such as 5-FU is selected by risk, site and actual product protocol; the original 6 weekcourse is not universally safe periocular treatment. Keratoacanthoma may grow rapidly with a central keratin plug and overlap SCC; obtain appropriate tissue and treatment rather than assuming a harmless lesion will regress. 1 6
05Recognise malignant patterns and choose adequate biopsy
Madarosis, destroyed meibomian openings, telangiectasia, ulceration, fixation and progressive change raise suspicion. Evert the lid and inspect conjunctiva. Histology is central; dermoscopy can support assessment but neither one warning sign nor benign appearance settles the diagnosis. A superficial shave is not a universal adequate sample for suspected invasive melanoma or sebaceous carcinoma, where depth and spread matter. 1 3 7 8
Basal-cell carcinoma(BCC) may be nodular with a pearly border, pigmented or morphoeic/infiltrative with subclinical extension. The original 90% frequency depends on tumour population and geography. SCC can metastasise and deserves particular vigilance in immunosuppressed/transplant patients. Histotype, site, depth, recurrence and perineural or orbital involvement guide risk rather than one fixed margin. 1 6
Sebaceous carcinoma can mimic recurrent chalazion or chronic unilateral blepharitis, with pagetoid epithelial spread and discontinuous skip lesions. Plan adequate tissue and selected conjunctival mapping according to suspected extent; a map biopsy is not established as compulsory for every tiny tumour regardless of findings. Melanoma prognosis includes Breslow thickness and other stage factors; preserve depth assessment when planning biopsy. 1 3 7
Historical S3 melanoma guidance favours complete diagnostic excision with a small margin when feasible, with selected partial sampling for difficult large facial lesions. A meta-analysis of 5 studies/3249 patients found partial-versus-excisional recurrenceRR 1.27 (95% CI 0.97–1.67) and melanoma-deathRR 1.50 (0.98–2.30). Predominantly retrospective selection and intervals permitting harm prove neither equivalence nor universal biopsy-induced metastasis; a partial sample may miss maximum thickness. 7 8
06Plan definitive margins and risk-based follow-up
Micrographically controlled surgery(MKC), including a suitable three-dimensional “Tübinger Torte” approach, can preserve tissue and assess subclinical spread. Selected frozen sections are not automatically complete margin control. The original BCC 2–3 mm and SCC≥5 mm examples do not apply regardless of histotype, risk, margin method or functional anatomy; coordinate oculoplastic/oncological resection and reconstruction. 1 6 7
For cutaneous eyelid melanoma, sentinel-node discussion depends on thickness, ulceration, staging and individual circumstances. The original>1.0 mm or>0.8 mm with ulceration and table>0.8–1.0 mm statements are not one verified universal threshold here; check the actual current melanoma pathway rather than transferring them automatically to every lid lesion. Follow-up every 3–6 months is a teaching example; stage, histotype, recurrence and second-tumour risk determine surveillance. 1
| Topic | Clinical concept | Selected management | Diagnostic clue | Limits / precautions |
|---|---|---|---|---|
| FES | Tarsal laxity/elastin changes | Surface protection, selected tightening/LTS/wedge; assess OSA | Rubbery tarsus and papillary conjunctivitis | CPAP mask leak differs from lacrimal air reflux, especially after DCR. |
| Chalazion | Lipogranulomatous inflammation | Warm compresses; selected incision/curettage | Often painless nodule | Vertical conjunctival incision is a technique point, not a universal recipe; atypical recurrence needs tumour assessment. |
| BCC | Original 90% frequency is population-dependent | Selected complete histological margin control | Pearly border and telangiectasia | Morphoeic/infiltrative extension can be subclinical. |
| SCC | Invasive/metastatic potential | Risk-based resection; original 5 mm is not universal | Ulcer, crust, hyperkeratosis | Immune suppression/transplant status increases concern. |
| Sebaceous carcinoma | Masquerades as inflammation | Adequate tissue and selected map biopsies | Recurrent chalazion/unilateral chronic blepharitis | Pagetoid spread and skip lesions; no automatic same biopsy for all. |
| Melanoma | Breslow/stage matter | Individual excision and sentinel-node assessment | ABCDE/change in pigmentation | Original>0.8–1.0 mm is not a universal verified sentinel rule. |
| Actinic keratosis | UV-associated keratinocyte atypia | Selected biopsy/excision or 5-FUfield treatment | Rough sandpaper-like surface | Periocular irritation and actual product/site protocol matter. |
| Naevus Ota | Oculodermal melanocytosis | Individual ocular/uveal surveillance | Blue-grey scleral/conjunctival pigmentation | Original 1:400 risk and annual interval need population and current guidance. |
What are the main learning points?
Examine the surface, lid margin and conjunctiva, recognise masquerade lesions and choose biopsy and tumour treatment by the actual diagnosis and risk.
When is assessment urgent?
Rapid visual decline, severe pain, spreading inflammation, corneal injury, pressure rise or neurological signs need urgent assessment. A persistent recurrent nodule, lash loss, ulceration or changing pigmented lesion warrants prompt specialist review.
References and access status
- 1Immutable original export; own complete eyelid-disease/tumour export
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 2AAO: Chalazion Management: Evidence and Questions
Historical Review 036 recorded access retained; Actual indexed selected management, biopsy and injection-risk text read; whole article and underlying studies not all read.
- 3AAO: Diagnosis and Management of Sebaceous Carcinoma of the Eyelid
Historical Review 036 recorded access retained; Actual indexed selected differential and biopsy text read; full oncological pathway unread.
- 4Wu et al. 2018, PMID 29338124
Historical Review 036 recorded access retained; Complete actual NCBI XML abstract read, after a truncated Europe PMC abstract; full paper access failed and methods/supplement not appraised.
- 5Goawalla and Lee 2007, PMID 17997772
Historical Review 036 recorded access retained; Complete actual NCBI XML abstract read; inconsistent comparative P-value wording retained as a limitation, not repaired by inference. Full paper unread.
- 6S3 AK / cutaneous SCC, Version 2.0, December 2022
Historical Review 032 access retained, not a new current/full-guideline reading; Actual selected sections 4.3,5.2 and 7.2–7.4 read, including printed pp 42, 62, 181–184; no whole-guideline or independent underlying-study appraisal.
- 7S3 Melanoma, Version 3.3, July 2020
Historical Review 032 access retained, not a new current/full-guideline reading; Actual section 4.3 recommendation 4.7 and explanatory text printed p 43 read. Historical version linked by the official catalog; not an asserted new 2026 guideline or whole-report appraisal.
- 8Moscarella et al. Partial versus excisional biopsy of melanoma
Historical Review 032 access retained, not a new current/full-guideline reading; Complete NCBI PubMed abstract read; main report, protocol and supplements unread. Predominantly retrospective evidence.
- 9OSA in FES systematic review/meta-analysis; PMID 36700854
Indexed title/design or purpose excerpt inspected 17 November 2026; complete abstract/report and study-level appraisal remain pending. No new pooled effect or complication rate adopted.
- 10CPAP effects after endoscopic DCR retrospective study; PMID 25495401
Indexed title/design or purpose excerpt inspected 17 November 2026; complete abstract/report and study-level appraisal remain pending. No new pooled effect or complication rate adopted.
- 11Air regurgitation after DCR/CPAP stent case; PMID 37565826
Indexed title/design or purpose excerpt inspected 17 November 2026; complete abstract/report and study-level appraisal remain pending. No new pooled effect or complication rate adopted.
- 12Original exported eyelid-lesion briefing
Historical Review 036 own-source identity retained; Complete captured export and all table cells read; recording, pathology slides and Kanski edition unverified.
For patients
An eyelid lump is often benign or inflammatory, but some tumours look similar. Examination, the course over time and sometimes a planned tissue sample establish the cause.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Rapid visual decline, severe pain, spreading inflammation, corneal injury, pressure rise or neurological signs need urgent assessment. A persistent recurrent nodule, lash loss, ulceration or changing pigmented lesion warrants prompt specialist review.
Rapid visual decline, severe pain, spreading inflammation, corneal injury, pressure rise or neurological signs need urgent assessment. A persistent recurrent nodule, lash loss, ulceration or changing pigmented lesion warrants prompt specialist review.